These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 839597

  • 41. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M, Lutherer S, Terhorst B.
    Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
    [Abstract] [Full Text] [Related]

  • 42. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977 Jul; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I.
    Orv Hetil; 1982 Jan 31; 123(5):287-9. PubMed ID: 7063244
    [No Abstract] [Full Text] [Related]

  • 45. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
    Gunnarsson PO, Forshell GP, Fritjofsson A, Norlén BJ.
    Scand J Urol Nephrol; 1981 Jan 31; 15(3):201-5. PubMed ID: 7323739
    [Abstract] [Full Text] [Related]

  • 46. Prednimustine for prostate cancer therapy.
    Slack NH, Murphy GP.
    Compr Ther; 1979 Sep 31; 5(9):54-7. PubMed ID: 487742
    [No Abstract] [Full Text] [Related]

  • 47. Preliminary clinical study of prednimustine in lung cancer.
    Catane H, Catane R, Takita H, Kaufman JH, Mittelman A, Murphy GP.
    J Med; 1977 Sep 31; 8(2):115-21. PubMed ID: 268397
    [Abstract] [Full Text] [Related]

  • 48. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L, Berlin T, Boman J, Collste L, Edsmyr F, Esposti PL, Gustafsson H, Hedlund PO, Hultgren L, Leander G, Nordle O, Norlén H, Tillegård P.
    Scand J Urol Nephrol Suppl; 1980 Sep 31; 55():143-5. PubMed ID: 6259722
    [Abstract] [Full Text] [Related]

  • 49. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T, Kubo T, Akasaka T, Funyu T, Yagihashi Y, Kudo T, Tsuchida S, Harada T, Sasaki S, Orikasa S.
    Hinyokika Kiyo; 1988 Aug 31; 34(8):1493-502. PubMed ID: 3057833
    [Abstract] [Full Text] [Related]

  • 50. Estramustine phosphate in the treatment of advanced prostatic cancer.
    Küss R, Khoury S, Richard F, Fourcade F, Frantz P, Capelle JP.
    Br J Urol; 1980 Feb 31; 52(1):29-33. PubMed ID: 7426949
    [Abstract] [Full Text] [Related]

  • 51. Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial institute.
    Murphy GP, Slack NH, Mittelman A.
    Urology; 1984 Jun 31; 23(6 Suppl):54-63. PubMed ID: 6375081
    [No Abstract] [Full Text] [Related]

  • 52. Estramustine phosphate sodium.
    Hauser AR, Merryman R.
    Drug Intell Clin Pharm; 1984 May 31; 18(5):368-74. PubMed ID: 6373212
    [Abstract] [Full Text] [Related]

  • 53. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J, Jung JL, Bittard M.
    J Urol (Paris); 1984 May 31; 90(1):27-33. PubMed ID: 6725973
    [Abstract] [Full Text] [Related]

  • 54. [Stage D1 prostatic cancer benefited by a single regimen of Estracyt].
    Hata M.
    Gan To Kagaku Ryoho; 1988 May 31; 15(5):1787-90. PubMed ID: 3369873
    [Abstract] [Full Text] [Related]

  • 55. Estramustine phosphate with multiple cytotoxic agents in treatment of advanced prostatic cancer.
    Beckley S, Wajsman Z, Maeso E, Pontes E, Murphy G.
    Urology; 1981 Dec 31; 18(6):592-5. PubMed ID: 7198328
    [Abstract] [Full Text] [Related]

  • 56. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T, Haukaas S.
    Invest Urol; 1981 May 31; 18(8):437-9. PubMed ID: 7228576
    [Abstract] [Full Text] [Related]

  • 57. [Estramustine phosphate in the treatment of stage D prostatic carcinoma].
    van Wyk J.
    S Afr Med J; 1978 Oct 14; 54(16):638. PubMed ID: 741271
    [No Abstract] [Full Text] [Related]

  • 58. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC, Cummings K.
    Prog Clin Biol Res; 1989 Oct 14; 303():177-86. PubMed ID: 2674984
    [No Abstract] [Full Text] [Related]

  • 59. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A, Shukla SK, Welvaart K, Murphy GP.
    Cancer Chemother Rep; 1975 Oct 14; 59(1):219-23. PubMed ID: 1093669
    [Abstract] [Full Text] [Related]

  • 60. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ, Morales A.
    Can J Surg; 1983 Sep 14; 26(5):434-8. PubMed ID: 6351988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.